Notable Analyst Rating Changes 05/01: (AMGN) (MSPD) (ULTI) Upgraded; (LSI) (OIS) (OKE) Downgraded
Tweet Send to a Friend
UPGRADES
Goldman Sachs boosts Amgen (Nasdaq: AMGN) from Neutral to Conviction Buy, adjusting its price target from $100 to $130 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs boosts Amgen (Nasdaq: AMGN) from Neutral to Conviction Buy, adjusting its price target from $100 to $130 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
